Почетна › Сквамозноклеточен карцином на глава и врат › Мисури › St. Louis
Клинички испитувања за Сквамозноклеточен карцином на глава и врат во St. Louis, MO
28 студии за Сквамозноклеточен карцином на глава и врат бараат учесници на локации во и околу St. Louis (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Се регрутираФаза 3
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · на 16 милји
- и уште 1
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Се регрутираФаза 1
- Washington University School of Medicine in St. Louis, St Louis
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Се регрутираФаза 2/3
- Site #0114, St Louis
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Се регрутираФаза 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- и уште 4
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Се регрутираФаза 3
- Washington University School Of Medicine, St Louis
- Cancer Care Specialists of Central Illinois, O'Fallon · на 16 милји
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Се регрутираФаза 1/2
- Washington University School Of Medicine, St Louis
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Се регрутираФаза 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- и уште 4
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Се регрутираФаза 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- HSHS Saint Elizabeth's Hospital, O'Fallon · на 16 милји
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Се регрутираФаза 1/2
- Washington University, St Louis
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Се регрутираФаза 1/2
- Washington Univ. School of Medicine, St Louis
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Се регрутираФаза 2
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- и уште 4
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Се регрутираФаза 1/2
- Washington University, St Louis
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Се регрутираФаза 1
- Washington University, St Louis
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Се регрутираНабљудувачка студија
- Washington University in St. Louis, St Louis
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Research Site, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Се регрутираФаза 1
- Normunity Investigational Site, St Louis
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Се регрутираФаза 2/3
- SSM Health Saint Louis University Hospital, St Louis
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Се регрутираФаза 3
- Cancer Care Center of O'Fallon, O'Fallon · на 16 милји
- HSHS Saint Elizabeth's Hospital, O'Fallon · на 16 милји
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Се регрутираФаза 1/2
- Washington University School of Medicine at St Louis, St Louis
Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
Се регрутираФаза 2
- Washington University School of Medicine, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- Washington University, St Louis
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Се регрутираФаза 3
- GSK Investigational Site, St Louis
5-Fluorouracil Response and Optimization STudy (The FROST Trial)
Се регрутираФаза 2
- Washington University School of Medicine, St Louis
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Се регрутираФаза 3
- Siteman Cancer Center - Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Washington University, St Louis
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Се регрутира
- Washington University in St. Louis, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Се регрутираФаза 1/2
- Washington University, St Louis
Validity of Viome's Oral/throat Cancer Test
Се регрутираНабљудувачка студија
- Missouri School of Dentistry & Oral Health, St Louis
Испитувања за Сквамозноклеточен карцином на глава и врат во други градови
- Houston, TX47 студии
- Los Angeles, CA42 студии
- Boston, MA40 студии
- New York City, NY39 студии
- Nashville, TN39 студии
- Arlington, VA26 студии
- Philadelphia, PA26 студии
- Chicago, IL26 студии
- Atlanta, GA24 студии
- San Antonio, TX22 студии
- New Haven, CT22 студии
- Pittsburgh, PA22 студии
Други студии во St. Louis
- Рак на бели дробови со не-мали клетки73 студии
- Рак на дојка64 студии
- Метастатски карцином54 студии
- Колоректален карцином50 студии
- Рак (сите типови)46 студии
- Рак на простата46 студии
- Рак на бели дробови39 студии
- Карцином на јајниците38 студии
- Карцином на панкреасот33 студии
- Рак на ендометриумот29 студии
- Срцева слабост26 студии
- Дебелина25 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.